Pages that link to "Q37141960"
Jump to navigation
Jump to search
The following pages link to The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer (Q37141960):
Displaying 50 items.
- Sirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular Effects (Q26749011) (← links)
- Systemic and nonrenal adverse effects occurring in renal transplant patients treated with mTOR inhibitors (Q26823023) (← links)
- Deregulated signaling pathways in glioblastoma multiforme: molecular mechanisms and therapeutic targets (Q26829873) (← links)
- Epilepsy related to developmental tumors and malformations of cortical development (Q26829946) (← links)
- Adipose stromal cells amplify angiogenic signaling via the VEGF/mTOR/Akt pathway in a murine hindlimb ischemia model: a 3D multimodality imaging study (Q27317398) (← links)
- Risk factors for GI adverse events in a phase III randomized trial of bevacizumab in first-line therapy of advanced ovarian cancer: A Gynecologic Oncology Group Study (Q30405727) (← links)
- Antivascular therapy for epithelial ovarian cancer (Q33583598) (← links)
- P70S6K 1 regulation of angiogenesis through VEGF and HIF-1alpha expression (Q34083360) (← links)
- PP242 suppresses cell proliferation, metastasis, and angiogenesis of gastric cancer through inhibition of the PI3K/AKT/mTOR pathway (Q34465116) (← links)
- Modulation, bioinformatic screening, and assessment of small molecular peptides targeting the vascular endothelial growth factor receptor (Q34474669) (← links)
- Immune response in ovarian cancer: how is the immune system involved in prognosis and therapy: potential for treatment utilization (Q34557233) (← links)
- Multiple genetic alterations within the PI3K pathway are responsible for AKT activation in patients with ovarian carcinoma (Q34586019) (← links)
- Effect of VEGF and VEGF Trap on vascular endothelial cell signaling in tumors (Q34616563) (← links)
- Overexpression of Tumor Vascular Endothelial Growth Factor A May Portend an Increased Likelihood of Progression in a Phase II Trial of Bevacizumab and Erlotinib in Resistant Ovarian Cancer (Q34781970) (← links)
- PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samples (Q35470322) (← links)
- Epithelial to mesenchymal transition in the liver field: the double face of Everolimus in vitro. (Q35775057) (← links)
- Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways (Q35837949) (← links)
- Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer (Q35954103) (← links)
- The OPCML tumor suppressor functions as a cell surface repressor-adaptor, negatively regulating receptor tyrosine kinases in epithelial ovarian cancer (Q36041745) (← links)
- Potential tumorigenic programs associated with TP53 mutation status reveal role of VEGF pathway (Q36385696) (← links)
- Hypoxia reduces placental mTOR activation in a hypoxia-induced model of intrauterine growth restriction (IUGR). (Q36597824) (← links)
- Stathmin Regulates Hypoxia-Inducible Factor-1α Expression through the Mammalian Target of Rapamycin Pathway in Ovarian Clear Cell Adenocarcinoma (Q36931508) (← links)
- RES-529: a PI3K/AKT/mTOR pathway inhibitor that dissociates the mTORC1 and mTORC2 complexes (Q36939659) (← links)
- Characterization of long non-coding RNA-associated ceRNA network to reveal potential prognostic lncRNA biomarkers in human ovarian cancer (Q37022234) (← links)
- Intraoperative imaging in ovarian cancer: fact or fiction? (Q37149571) (← links)
- Migration-inducing gene 7 promotes tumorigenesis and angiogenesis and independently predicts poor prognosis of epithelial ovarian cancer (Q37317324) (← links)
- Angiogenesis and ovarian cancer. (Q37602374) (← links)
- The rationale for mTOR inhibition in epithelial ovarian cancer (Q37627253) (← links)
- Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cells (Q37739569) (← links)
- Targeted Agents in Ovarian Cancer (Q37795802) (← links)
- Ovarian cancer molecular pathology. (Q38021356) (← links)
- Therapeutic potential of cancer stem cells (Q38446739) (← links)
- Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase (Q39060681) (← links)
- Impaired CD98 signaling protects against graft-versus-host disease by increasing regulatory T cells. (Q40031867) (← links)
- Overcoming intratumoural heterogeneity for reproducible molecular risk stratification: a case study in advanced kidney cancer (Q41047932) (← links)
- Advanced alveolar soft part sarcoma responds to apatinib (Q41473058) (← links)
- Signature microRNAs in human cornea limbal epithelium (Q42469996) (← links)
- BRAF V600E mutation is associated with mTOR signaling activation in glioneuronal tumors (Q45865000) (← links)
- Metastasis-associated protein 2 promotes the metastasis of non-small cell lung carcinoma by regulating the ERK/AKT and VEGF signaling pathways (Q47639200) (← links)
- pS6 Expression in normal renal parenchyma, primary renal cell carcinomas and their metastases. (Q53714945) (← links)
- SP1-induced lncRNA-ZFAS1 contributes to colorectal cancer progression via the miR-150-5p/VEGFA axis (Q58700714) (← links)
- Targeted therapies in epithelial ovarian cancer (Q59305026) (← links)
- miR-125a-5p suppresses colorectal cancer progression by targeting VEGFA (Q59797736) (← links)
- miR-150-5p suppresses tumor progression by targeting VEGFA in colorectal cancer (Q60050050) (← links)
- P53-induced miR-1249 inhibits tumor growth, metastasis, and angiogenesis by targeting VEGFA and HMGA2 (Q61796574) (← links)
- Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms (Q61804671) (← links)
- Anti-tumorigenic and Platinum-Sensitizing Effects of Apolipoprotein A1 and Apolipoprotein A1 Mimetic Peptides in Ovarian Cancer (Q61808030) (← links)
- SP1-induced lncRNA TINCR overexpression contributes to colorectal cancer progression by sponging miR-7-5p (Q64110503) (← links)
- The Communication Between the PI3K/AKT/mTOR Pathway and Y-box Binding Protein-1 in Gynecological Cancer (Q92702379) (← links)
- Risk of Dyslipidemia Associated with VEGF/VEGFR Inhibitors: A Meta-Analysis (Q94572238) (← links)